Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Linhui Hao, Tien-Ying Hsiang, Ronit R. Dalmat, Renee Ireton, Jennifer Morton, Caleb Stokes, Jason Netland, Malika Hale, Chris Thouvenel, Anna Wald, Nicholas M Franko, Kristen Huden, Helen Chu, Alex Greninger, Sasha Tilles, Lynn K. Barrett, Wesley C. Van Voorhis, Jennifer Munt, Trevor Scobey, Ralph S. Baric, David Rawlings, Marion Pepper, Paul K. Drain, Michael Gale Jr.
doi: https://doi.org/10.1101/2022.08.12.22278720
Linhui Hao
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
Tien-Ying Hsiang
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
Ronit R. Dalmat
3International Clinical Research Center, Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA
4Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA
Renee Ireton
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
Jennifer Morton
3International Clinical Research Center, Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA
4Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA
Caleb Stokes
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
5Department of Pediatrics, School of Medicine, University of Washington, Seattle WA
Jason Netland
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
Malika Hale
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
Chris Thouvenel
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
Anna Wald
4Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
7Allergy and Infectious Diseases Division, Laboratory Medicine & Pathology, & Epidemiology, University of Washington, Seattle, WA
8Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Center, Seattle, WA
Nicholas M Franko
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Kristen Huden
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Helen Chu
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Alex Greninger
9Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA
Sasha Tilles
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Lynn K. Barrett
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Wesley C. Van Voorhis
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Jennifer Munt
10Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill NC
Trevor Scobey
10Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill NC
Ralph S. Baric
10Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill NC
David Rawlings
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
Marion Pepper
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
Paul K. Drain
3International Clinical Research Center, Department of Global Health, Schools of Medicine and Public Health, University of Washington, Seattle, WA
4Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA
6Division of Allergy and Infectious Diseases, Department of Medicine, School of Medicine, University of Washington, Seattle, WA
Michael Gale Jr.
1Department of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA
2Center for Emerging & Re-emerging Infectious Diseases, University of Washington, Seattle, WA
Data Availability
All data produced in the present work are contained in the manuscript
Posted August 16, 2022.
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Linhui Hao, Tien-Ying Hsiang, Ronit R. Dalmat, Renee Ireton, Jennifer Morton, Caleb Stokes, Jason Netland, Malika Hale, Chris Thouvenel, Anna Wald, Nicholas M Franko, Kristen Huden, Helen Chu, Alex Greninger, Sasha Tilles, Lynn K. Barrett, Wesley C. Van Voorhis, Jennifer Munt, Trevor Scobey, Ralph S. Baric, David Rawlings, Marion Pepper, Paul K. Drain, Michael Gale Jr.
medRxiv 2022.08.12.22278720; doi: https://doi.org/10.1101/2022.08.12.22278720
Dynamics of SARS-CoV-2 VOC neutralization and novel mAb reveal protection against Omicron
Linhui Hao, Tien-Ying Hsiang, Ronit R. Dalmat, Renee Ireton, Jennifer Morton, Caleb Stokes, Jason Netland, Malika Hale, Chris Thouvenel, Anna Wald, Nicholas M Franko, Kristen Huden, Helen Chu, Alex Greninger, Sasha Tilles, Lynn K. Barrett, Wesley C. Van Voorhis, Jennifer Munt, Trevor Scobey, Ralph S. Baric, David Rawlings, Marion Pepper, Paul K. Drain, Michael Gale Jr.
medRxiv 2022.08.12.22278720; doi: https://doi.org/10.1101/2022.08.12.22278720
Subject Area
Subject Areas
- Addiction Medicine (354)
- Allergy and Immunology (680)
- Anesthesia (182)
- Cardiovascular Medicine (2692)
- Dermatology (227)
- Emergency Medicine (404)
- Epidemiology (12326)
- Forensic Medicine (10)
- Gastroenterology (771)
- Genetic and Genomic Medicine (4164)
- Geriatric Medicine (392)
- Health Economics (688)
- Health Informatics (2702)
- Health Policy (1010)
- Hematology (366)
- HIV/AIDS (864)
- Medical Education (401)
- Medical Ethics (110)
- Nephrology (446)
- Neurology (3947)
- Nursing (214)
- Nutrition (587)
- Oncology (2076)
- Ophthalmology (596)
- Orthopedics (244)
- Otolaryngology (308)
- Pain Medicine (253)
- Palliative Medicine (75)
- Pathology (474)
- Pediatrics (1133)
- Primary Care Research (462)
- Public and Global Health (6590)
- Radiology and Imaging (1428)
- Respiratory Medicine (877)
- Rheumatology (415)
- Sports Medicine (345)
- Surgery (455)
- Toxicology (55)
- Transplantation (191)
- Urology (170)